Thomas C, Gustafsson JÅ: The different roles of ER subtypes in cancer biology and therapy. Nat Rev Cancer. 2011, 11 (8): 597-608. 10.1038/nrc3093.
Article
CAS
PubMed
Google Scholar
Fishman J, Osborne MP, Telang NT: The role of estrogen in mammary carcinogenesis. Ann N Y Acad Sci. 1995, 768: 91-100. 10.1111/j.1749-6632.1995.tb12113.x.
Article
CAS
PubMed
Google Scholar
Liehr JG: Is estradiol a genotoxic mutagenic carcinogen?. Endocr Rev. 2000, 21 (1): 40-54.
CAS
PubMed
Google Scholar
Devanesan P, Santen RJ, Bocchinfuso WP, Korach KS, Rogan EG, Cavalieri E: Catechol estrogen metabolites and conjugates in mammary tumors and hyperplastic tissue from estrogen receptor-alpha knock-out (ERKO)/Wnt-1 mice: implications for initiation of mammary tumors. Carcinogenesis. 2001, 22 (9): 1573-1576. 10.1093/carcin/22.9.1573.
Article
CAS
PubMed
Google Scholar
Russo J, Russo IH: The role of estrogen in the initiation of breast cancer. J Steroid Biochem Mol Biol. 2006, 102 (1–5): 89-96.
Article
CAS
PubMed
PubMed Central
Google Scholar
Yager JD, Davidson NE: Estrogen carcinogenesis in breast cancer. NEJM. 2006, 354 (3): 270-282. 10.1056/NEJMra050776.
Article
CAS
PubMed
Google Scholar
Hammond ME, Hayes DF, Dowsett M, Allred DC, Hagerty KL, Badve S, Fitzgibbons PL, Francis G, Goldstein NS, Hayes M, Hicks DG, Lester S, Love R, Mangu PB, McShane L, Miller K, Osborne CK, Paik S, Perlmutter J, Rhodes A, Sasano H, Schwartz JN, Sweep FC, Taube S, Torlakovic EE, Valenstein P, Viale G, Visscher D, Wheeler T, Williams RB, et al: American Society of Clinical Oncology; College of American Pathologists. (2010). American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer (unabridged version). Arch Pathol Lab Med. 2010, 134 (7): e48-e72.
CAS
PubMed
Google Scholar
Viale G, Regan MM, Maiorano E, Mastropasqua MG, Dell’Orto P, Rasmussen BB, Raffoul J, Neven P, Orosz Z, Braye S, Ohlschlegel C, Thürlimann B, Gelber RD, Castiglione-Gertsch M, Price KN, Goldhirsch A, Gusterson BA, Coates AS: Prognostic and predictive value of centrally reviewed expression of estrogen and progesterone receptors in a randomized trial comparing letrozole and tamoxifen adjuvant therapy for postmenopausal early breast cancer: BIG 1–98. J Clin Oncol. 2007, 25 (25): 3846-3852. 10.1200/JCO.2007.11.9453.
Article
PubMed
Google Scholar
Endo Y, Toyama T, Takahashi S, Sugiura H, Yoshimoto N, Iwasa M, Kobayashi S, Fujii Y, Yamashita H: High estrogen receptor expression and low Ki67 expression are associated with improved time to progression during first-line endocrine therapy with aromatase inhibitors in breast cancer. Int J Clin Oncol. 2011, 16 (5): 512-518. 10.1007/s10147-011-0215-5.
Article
CAS
PubMed
Google Scholar
Khalique L, Ayhan A, Weale ME, Jacobs IJ, Ramus SJ, Gayther SA: Genetic intra-tumour heterogeneity in epithelial ovarian cancer and its implications for molecular diagnosis of tumours. J Pathol. 2007, 211 (3): 286-295. 10.1002/path.2112.
Article
CAS
PubMed
Google Scholar
Li JQ, Xu BJ, Shakhtour B, Deane N, Merchant N, Heslin MJ, Washington K, Coffey RJ, Beauchamp RD, Shyr Y, Billheimer D: Variability of in situ proteomic profiling and implications for study design in colorectal tumors. Int J Oncol. 2007, 31 (1): 103-111.
PubMed
Google Scholar
Iwasa Y, Michor F: Evolutionary dynamics of intratumor heterogeneity. PLoS One. 2011, 6 (3): e17866-10.1371/journal.pone.0017866.
Article
CAS
PubMed
PubMed Central
Google Scholar
Gerlinger M, Rowan AJ, Horswell S, Larkin J, Endesfelder D, Gronroos E, Martinez P, Matthews N, Stewart A, Tarpey P, Varela I, Phillimore B, Begum S, McDonald NQ, Butler A, Jones D, Raine K, Latimer C, Santos CR, Nohadani M, Eklund AC, Spencer-Dene B, Clark G, Pickering L, Stamp G, Gore M, Szallasi Z, Downward J, Futreal PA, Swanton C: Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N Engl J Med. 2012, 366 (10): 883-892. 10.1056/NEJMoa1113205.
Article
CAS
PubMed
PubMed Central
Google Scholar
Swanton C: Intratumor heterogeneity: evolution through space and time. Cancer Res. 2012, 72 (19): 4875-4882. 10.1158/0008-5472.CAN-12-2217.
Article
CAS
PubMed
PubMed Central
Google Scholar
Alfarouk KO, Ibrahim ME, Gatenby RA, Brown JS: Riparian ecosystems in human cancers. Evol Appl. 2013, 6 (1): 46-53. 10.1111/eva.12015.
Article
PubMed
Google Scholar
Pinzone JJ, Stevenson H, Strobl JS, Berg PE: Molecular and cellular determinants of estrogen receptor α expression. Mol Cell Biol. 2004, 24 (11): 4605-4612. 10.1128/MCB.24.11.4605-4612.2004.
Article
CAS
PubMed
PubMed Central
Google Scholar
Stoner M, Saville B, Wormke M, Dean D, Burghardt R, Safe S: Hypoxia induces proteasome-dependent degradation of estrogen receptor α in ZR-75 breast cancer cells. Mol Endocrinol. 2002, 16 (10): 2231-2242. 10.1210/me.2001-0347.
Article
CAS
PubMed
Google Scholar
Shipitsin M, Campbell LL, Argani P, Weremowicz S, Bloushtain-Qimron N, Yao J, Nikolskaya T, Serebryiskaya T, Beroukhim R, Hu M, Halushka MK, Sukumar S, Parker LM, Anderson KS, Harris LN, Garber JE, Richardson AL, Schnitt SJ, Nikolsky Y, Gelman RS, Polyakemail K: “Molecular definition of breast tumor heterogeneity”. Cancer Cell. 2007, 11 (3): 259-273. 10.1016/j.ccr.2007.01.013.
Article
CAS
PubMed
Google Scholar
Jiang Y, Pjesivac J, Freyer J: A Cellular Model for Avascular Tumor Growth. Abstracts of ICSB 2002, the 3rd International Conference on System Biology—“The Logic of Life”. 2002, Stockholm, Sweden: Karolinska Institutet, 123-124. http://www.ki.se/icsb2002/abstracts.html,
Google Scholar
Qureshi A, Pervez S: Allred scoring for ER reporting and it’s impact in clearly distinguishing ER negative from ER positive breast cancers. J Pak Med Assoc. 2010, 60 (5): 350-353.
PubMed
Google Scholar
Harvey JM, Clark GM, Osborne CK, Allred DC: Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer. J Clin Oncol. 1999, 17 (5): 1474-1474.
CAS
PubMed
Google Scholar
Elston CW, Ellis IO: Pathological prognostic factors in breast cancer. The value of histological grade in breast cancer: experience from a large study with long‒term follow up. Histopathology. 1991, 19 (5): 403-410. 10.1111/j.1365-2559.1991.tb00229.x.
Article
CAS
PubMed
Google Scholar
Kunz P, Hoffend J, Altmann A, Dimitrakopoulou-Strauss A, Koczan D, Eisenhut M, Bonaterra GA, Dengler TJ, Mier W, Haberkorn U, Kinscherf R: Angiopoietin-2 overexpression in morris hepatoma results in increased tumor perfusion and induction of critical angiogenesis-promoting genes. J Nucl Med. 2006, 47 (9): 1515-1524.
CAS
PubMed
Google Scholar
Sorensen AG, Emblem KE, Polaskova P, Jennings D, Kim H, Ancukiewicz M, Wang M, Wen PY, Ivy P, Batchelor TT, Jain RK: Increased survival of glioblastoma patients who respond to antiangiogenic therapy with elevated blood perfusion. Cancer Res. 2012, 72 (2): 402-407. 10.1158/0008-5472.CAN-11-2464.
Article
CAS
PubMed
Google Scholar
Overgaard J, Horsman MR: Modification of hypoxia-induced radioresistance in tumors by the use of oxygen and sensitizers. Semin Radiat Oncol. 1996, 6: 10-21. 10.1016/S1053-4296(96)80032-4.
Article
PubMed
Google Scholar
Bernards R: Cancer: cues for migration. Nature. 2003, 425 (6955): 247-248. 10.1038/425247a.
Article
CAS
PubMed
Google Scholar
Clavo B, Robaina F, Catalá L, Pérez JL, Lloret M, Caramés MA, Morera J, López L, Suárez G, Macías D, Rivero J, Hernández MA: Effect of cervical spinal cord stimulation on regional blood flow and oxygenation in advanced head and neck tumours. Ann Oncol. 2004, 15 (5): 802-807. 10.1093/annonc/mdh189.
Article
CAS
PubMed
Google Scholar
Jain RK: Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy. Science. 2005, 307 (5706): 58-62. 10.1126/science.1104819.
Article
CAS
PubMed
Google Scholar
Teschendorff AE, Miremadi A, Pinder SE, Ellis IO, Caldas C: An immune response gene expression module identifies a good prognosis subtype in estrogen receptor negative breast cancer. Genome Biol. 2007, 8 (8): R157-10.1186/gb-2007-8-8-r157.
Article
PubMed
PubMed Central
Google Scholar
Fitzgibbons PL, Page DL, Weaver D, Thor AD, Allred DC, Clark GM, Ruby SG, O’Malley F, Simpson JF, Connolly JL, Hayes DF, Edge SB, Lichter A, Schnitt SJ: Prognostic factors in breast cancer. College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med. 2000, 124 (7): 966-978.
CAS
PubMed
Google Scholar
Vaupel P: Hypoxia in neoplastic tissue. Microvasc Res. 1977, 13 (3): 399-408. 10.1016/0026-2862(77)90106-6.
Article
CAS
PubMed
Google Scholar
Bosari S, Lee AK, DeLellis RA, Wiley BD, Heatley GJ, Silverman ML: Microvessel quantitation and prognosis in invasive breast carcinoma. Hum Pathol. 1992, 23 (7): 755-761. 10.1016/0046-8177(92)90344-3.
Article
CAS
PubMed
Google Scholar
Leek RD, Landers RJ, Harris AL, Lewis CE: Necrosis correlates with high vascular density and focal macrophage infiltration in invasive carcinoma of the breast. Br J Cancer. 1999, 79 (5/6): 991-
Article
CAS
PubMed
PubMed Central
Google Scholar